Impact of post-procedural intravascular ultrasound findings on long-term results following self-expanding nitinol stenting in superficial femoral artery lesions

Circulation Journal

Volumn 77, Issue 6, 2013, Pages 1543-1550

  Miki, Kojiro ^a   Fujii, Kenichi ^a   Fukunaga, Masashi ^a   Kawasaki, Daizo ^a   Shibuya, Masahiko ^a   Imanaka, Takahiro ^a   Tamaru, Hiroto ^a   Masutani, Motomaru ^a   Ohyanagi, Mitsumasa ^a   Masuyama, Tohru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Endovascular therapy; Intravascular ultrasound; Restenosis; Self expanding nitinol stent; Superficial femoral artery

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; ECHOPLAQUE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; UNCLASSIFIED DRUG;

AGED; ANGIOGRAPHY; ARTERY LESION; ARTICLE; CATHETER; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; INCIDENCE; INTRAVASCULAR ULTRASOUND; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NITINOL STENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUALITY OF LIFE; RESTENOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; SUPERFICIAL FEMORAL ARTERY;

AGED; AGED, 80 AND OVER; ALLOYS; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; RISK FACTORS; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84878235857     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1182     Document Type: Article

References (29)

1. Rowe VL, Lee W, Weaver FA, Etzioni D. Pattern of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg 2009; 49: 910-917.
2. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31: S1-S296.
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Haris KA, Fowkes FG. TASC II Working Group: Inter-Society Consensus for the Management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 43: S1-S67.
4. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-1888.
5. Vogel TR, Shindelman LE, Nackman GB, Graham AM. Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg 2003; 38: 1178-1184.
6. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007; 115: 2745-2749.
7. Tobis JM, Mallery J, Mahon D, Lehmann K, Zalesky P, Griffth J, et al. Intravascular ultrasound imaging of human coronary arteries in vivo: Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation 1991; 83: 913-926.
8. Kasaoka S, Tobis JM, Akiyama T, Reimers B, Mario CD, Wong ND, et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 1998; 32: 1630-1635.
9. Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, Satler LF, et al. Predictors of subacute stent thrombosis: Results of a systematic intravascular ultrasound study. Circulation 2003; 108: 43-47.
10. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS): A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001; 37: 1478-1492.
11. Ranke C, Creutzig A, Alexander K. Duplex scanning of peripheral arteries: Correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 1992; 18: 433-440.
12. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, et al. Nitinol stent implantation versus percutaneous trans-luminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation 2007; 116: 285-292.
13. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009; 74: 1090-1095.
14. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-month results. Circulation 2002; 106: 1505-1509.
15. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Olive V, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trial. J Endovasc Ther 2006; 13: 701-710.
16. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Dohi T, et al. Long-term results of endovascular therapy with nitinol stent implantation for TASC II A/B femoro-popliteal artery lesions: 4 years' experience. Circ J 2009; 73: 2143-2147.
17. Iida O, Uematsu M, Soga Y, Hirano K, Suzuki K, Yokoi H, et al. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses. Catheter Cardiovasc Interv 2011; 78: 611-617.
18. Suzuki K, Iida O, Soga Y, Hirano K, Inoue N, Uematsu M, et al. Long-term results of the S.M.A.R.T. Control™ stent for superficial femoral artery lesions, J-SMART registry. Circ J 2011; 75: 939-944.
19. Soga Y, Iida O, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M. Reste-nosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol. Catheter Cardiovasc Interv 2012; 79: 541-548.
20. Soga Y, Iida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M. Midterm clinical outcome and predictors of vessel patiency after femoro-popliteal stenting with self-expandable nitinol stent. J Vasc Surg 2010; 52: 608-615.
21. Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforsc-hung 1985; 35: 1144-1149.
22. Ikeda Y, Kikuchi M, Murakami H, Satoh K, Murata M, Watanabe K, et al. Comparison of the inhibitory effects of cilostazol, acetylsali-cylic acid, and ticlopidine on platelet functions ex vivo. Arzneimit-telforschung 1987; 37: 563-566.
23. Morishita R. A scientifc rationale for the CREST trial results: Evidence for the mechanism of action of cilostazol in restenosis. Athero-scler Suppl 2005; 6: 41-46.
24. Nakamura M, Kataoka T, Honda Y, Bonneau HN, Hibi K, Kitamura K, et al. Late incomplete stent apposition and focal vessel expansion after bare metal stenting. Am J Cardiol 2003; 92: 1217-1219.
25. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Satler LF, Kent KM, et al. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
26. Schulz C, Herrmann RA, Beilharz C, Pasquantonio J, Alt E. Coronary stent symmetry and vascular injury determine experimental re-stenosis. Heart 2000; 83: 462-467.
27. Han RO, Schwartz RS, Kobayashi Y, Wilson SH, Mann JT, Sketch RD, et al. Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis. Am J Cardiol 2001; 88: 253-259.
28. Nishida T, Colombo A, Briguori C, Stankovic G, Albiero R, Corvaja N, et al. Outcome of nonobstructive residual dissections detected by intravascular ultrasound following percutaneous coronary intervention. Am J Cardiol 2002; 89: 1257-1262.
29. Iida O, Soga Y, Hirano K, Okamoto S, Dohi T, Uematsu M, et al. Retrospective multicentre analysis of S.M.A.R.T. vs. Luminexx ni-tinol stent implantation for superfcial femoral artery lesions (REAL SL) Registry: 5 years' experience. Circ J 2011; 75: 421-427.